Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors
Antineoplastic Combined Chemotherapy Protocols
Neoplasms, Germ Cell and Embryonal
Four cycles of EP is a highly effective therapy for patients with good-risk GCT, with a high cure rate, low relapse rate, and little evidence of late relapse. Postchemotherapy surgery resection of residual disease remains an important aspect of treatment for these patients. Four cycles of EP is acceptable as a standard regimen for the treatment of good-risk metastatic GCT, and serves as an alternative to three cycles of bleomycin and etoposide before cisplatin.